Congenital colour vision defects (CVD) are common, inherited (most commonly X linked), non-progressive, and untreatable disorders.
At 7 years, CVD and mathematics and reading scores were not significantly associated, after adjustment for age at testing and factors described above (table) . At 16, after additional adjustment for prior test scores, children with CVD scored higher than those without; but the small differences, although statistically significant, were functionally unimportant (0.08 standard deviations; 0.002 to 0.16; P = 0.05 for mathematics and 0.07; 0.002 to 0.14; P = 0.04 for reading). There were no significant differences, by colour vision status, for boys or girls, in scores for "copy a design" or "draw a man" at 7 years. Highest educational qualification and colour vision status were not associated for either men or women ( 2 trend, P = 0.07 and P = 0.61). Risk of unintentional injury did not differ significantly (table) . Overall, 8.9% (8.2% to 9.6%) of females and 19.2% (18.2% to 20.2%) of males had road injuries as a driver by 33 years; people with CVD reported fewer unintentional injuries (P = 0.08 and P = 0.05). At 33 years, 30% (28.9% to 31.2%) of men reported unintentional injuries in the workplace, without any increased risk in those with colour vision defects (P = 0.293).
Comment
Increasing use of colour in education has raised concerns for children with CVD, but robust evidence is lacking. 5 Our findings indicate that affected children do as well as their peers educationally, during school and subsequently. Although the use of colour has increased since the early schooling of the subjects of this study, only a minority with severely impaired colour vision would be potentially disadvantaged and any limitation would depend on the specific environment as well as the individual's abilities.
That unintentional injuries were no more common among those with CVD supports current standards for driving in the United Kingdom (in which CVD is not a preclusion) and also indicates that normal colour vision is not a prerequisite for safe working in many occupations or environments.
Most people with colour vision defects develop effective adaptive strategies and behaviours, and they use other clues, such as a colour's saturation, to deal with any potential limitations in their professional and personal lives.
1 At a population level, congenital CVD confers no functional disadvantage in relation to educational attainment and unintentional injury. This challenges the rationale for and the value of population screening for these disorders.
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QT interval increased after single dose of lofexidine
John Schmittner, Jennifer R Schroeder, David H Epstein, Kenzie L Preston Lofexidine (BritLofex, Britannia) is an 2 agonist used for opioid detoxification. 1 We report one case of an increased QT interval after one dose of 0.4 mg lofexidine. 2 A 44 year old white opiate dependent female enrolled in a protocol to assess the safety of taking daily lofexidine with daily methadone. She had no known drug allergies, took no other drugs, and had never taken lofexidine before.
An electrocardiogram before starting methadone showed sinus rhythm (70 beats/min) and QT/QTc 428/462 ms. After stabilisation on methadone at 80 mg a day, an electrocardiogram still showed sinus rhythm (67 beats/min) and QT/QTc 428/449 ms (fig). She was then given lofexidine with her daily dose of methadone, which was followed by brief hypotension (88/55 mm Hg) with mild drowsiness. Four hours after taking lofexidine, an electrocardiogram showed sinus bradycardia (58 beats/min), QT/QTc 612/601 ms, and blood pressure 149/88 mm Hg (fig). The participant was otherwise asymptomatic. Within 24 hours, QT/QTc was 372/432 ms. Laboratory work found no abnormalities. Echocardiography showed mild mitral regurgitation.
Three independent cardiologists interpreted that although there was some QT prolongation (QT range 510-560 ms; QTc range 501-560), the computer overestimated the interval because of U waves.
Increased QT interval with lofexidine has been seen in animals, but only at very high doses 3 ; no clinically important changes have been seen in humans. Although high doses of methadone have been associated with changes in QT and arrhythmia, 4 the woman in this case had a normal QT interval while on methadone. The temporal relationship and lack of other causes indicate that the combination of lofexidine and methadone perhaps was the precipitant of this self limited change in QT.
In response, Britannia reported this event to the United Kingdom Committee on Safety of Medicines and added a warning to the summary of product characteristics (see www.lofexidine.co.uk). Before initiating lofexidine, clinicians may want to screen patients who might be at risk for repolarisation abnormalities. 
What is already known on this topic
Congenital colour vision defects are common, non-progressive, and untreatable disorders, for which screening is done so that affected children can be informed about occupations which require normal colour vision Little population based work exists on the broader functional impact of these disorders 
What this study adds

